Yahoo Web Search

Search results

    • Q1 2024 Y-mAbs Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      We remain very encouraged by what we've seen. So far to date, no patients in the trial have experienced any dose-limiting toxicities and there have been no instances of treatment related serious ...